Those who are diagnosed with cancer face a hard decision: Treatment or not? People respond to treatment differently. Doctors have backlogs of data that show how different patients responded to different treatments, but they are unanalyzed, and analyzing them would take years. Enter Reverse The Odds, a mobile game that shows players slides from a cancer patient and asks the player something like “was there blue on the slide?” The slides are pictures of proteins—biomarkers that are key to showing how a patient responded to certain treatments. If lets say the biomarker is blue, and the patient responded well to treatment, then researchers might be able to draw the conclusion that patients with similar biomarkers should opt for treatment. The task is easy but requires a human’s eye and intellect, a computer cannot analyze the raw data. Reverse The Odds is rudimentary, but that’s the point—to breakdown these massive data sets into pieces that anyone can understand, and help analyze. Hopefully making one of life’s hardest decisions easier.
Help cancer patients by playing a mobile game
More of Today's Solutions
More US states and cities are boosting minimum wages in 2026. What does it me...
BY THE OPTIMIST DAILY EDITORIAL TEAM As the federal minimum wage remains frozen at $7.25 an hour, unchanged since 2009, cities and states across ...
Read More3 organization hacks for Type B brains that actually work
BY THE OPTIMIST DAILY EDITORIAL TEAM Scroll through any productivity blog or time-management book, and you’ll find a familiar formula: rigid routines, detailed planners, ...
Read MoreAn easy hack to counteract the harmful health effects of sitting all day
Humans are not designed to spend the entire day seated. Nonetheless, billions of us do it at least five days per week, as Western ...
Read MoreEnsuring no pet goes hungry: The rise of pet food banks in the UK
Pete Dolan, a cat owner, recalls the tremendous help he received from Animal Food Bank Support UK, a Facebook organization that coordinates volunteer community ...
Read More
